» Articles » PMID: 32982693

Synaptic Organizers in Alzheimer's Disease: A Classification Based on Amyloid-β Sensitivity

Overview
Specialty Cell Biology
Date 2020 Sep 28
PMID 32982693
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Synaptic pathology is one of the major hallmarks observed from the early stage of Alzheimer's disease (AD), leading to cognitive and memory impairment characteristic of AD patients. Synaptic connectivity and specificity are regulated by multiple trans-bindings between pre- and post-synaptic organizers, the complex of which exerts synaptogenic activity. Neurexins (NRXs) and Leukocyte common antigen-related receptor protein tyrosine phosphatases (LAR-RPTPs) are the major presynaptic organizers promoting synaptogenesis through their distinct binding to a wide array of postsynaptic organizers. Recent studies have shown that amyloid-β oligomers (AβOs), a major detrimental molecule in AD, interact with NRXs and neuroligin-1, an NRX-binding postsynaptic organizer, to cause synaptic impairment. On the other hand, LAR-RPTPs and their postsynaptic binding partners have no interaction with AβOs, and their synaptogenic activity is maintained even in the presence of AβOs. Here, we review the current evidence regarding the involvement of synaptic organizers in AD, with a focus on Aβ synaptic pathology, to propose a new classification where NRX-based and LAR-RPTP-based synaptic organizing complexes are classified into Aβ-sensitive and Aβ-insensitive synaptic organizers, respectively. We further discuss how their different Aβ sensitivity is involved in Aβ vulnerability and tolerance of synapses for exploring potential therapeutic approaches for AD.

Citing Articles

Rare missense variants of the leukocyte common antigen related receptor (LAR) display reduced activity in transcellular adhesion and synapse formation.

Kaas M, Chofflet N, Bicer D, Skeldal S, Duan J, Feller B bioRxiv. 2025; .

PMID: 40027832 PMC: 11870473. DOI: 10.1101/2025.02.16.638491.


Sex-dependent molecular landscape of Alzheimer's disease revealed by large-scale single-cell transcriptomics.

Soudy M, Bars S, Glaab E Alzheimers Dement. 2024; 21(2):e14476.

PMID: 39737748 PMC: 11848167. DOI: 10.1002/alz.14476.


Dystroglycan-HSPG interactions provide synaptic plasticity and specificity.

Melrose J Glycobiology. 2024; 34(10).

PMID: 39223703 PMC: 11368572. DOI: 10.1093/glycob/cwae051.


Genome-wide epistasis analysis reveals gene-gene interaction network on an intermediate endophenotype P-tau/Aβ ratio in ADNI cohort.

Zhang Q, Liu J, Liu H, Ao L, Xi Y, Chen D Sci Rep. 2024; 14(1):3984.

PMID: 38368488 PMC: 10874417. DOI: 10.1038/s41598-024-54541-8.


Ferroptosis: underlying mechanisms and involvement in neurodegenerative diseases.

Wang Y, Li H, He Q, Zou R, Cai J, Zhang L Apoptosis. 2023; 29(1-2):3-21.

PMID: 37848673 DOI: 10.1007/s10495-023-01902-9.


References
1.
Reissner C, Runkel F, Missler M . Neurexins. Genome Biol. 2013; 14(9):213. PMC: 4056431. DOI: 10.1186/gb-2013-14-9-213. View

2.
Yoshida T, Yasumura M, Uemura T, Lee S, Ra M, Taguchi R . IL-1 receptor accessory protein-like 1 associated with mental retardation and autism mediates synapse formation by trans-synaptic interaction with protein tyrosine phosphatase δ. J Neurosci. 2011; 31(38):13485-99. PMC: 6623287. DOI: 10.1523/JNEUROSCI.2136-11.2011. View

3.
Wang Q, Rowan M, Anwyl R . Beta-amyloid-mediated inhibition of NMDA receptor-dependent long-term potentiation induction involves activation of microglia and stimulation of inducible nitric oxide synthase and superoxide. J Neurosci. 2004; 24(27):6049-56. PMC: 6729673. DOI: 10.1523/JNEUROSCI.0233-04.2004. View

4.
Basavarajappa B, Shivakumar M, Joshi V, Subbanna S . Endocannabinoid system in neurodegenerative disorders. J Neurochem. 2017; 142(5):624-648. PMC: 5669051. DOI: 10.1111/jnc.14098. View

5.
Li Z, Sheng M . Some assembly required: the development of neuronal synapses. Nat Rev Mol Cell Biol. 2003; 4(11):833-41. DOI: 10.1038/nrm1242. View